TOTAL SYNTHESIS OF THE ACTIVE INGREDIENT ACETYL TETRAPEPTIDE-3 FOR HAIR LOSS TREATMENT AND SCALP CARE
DOI:
https://doi.org/10.18173/2354-1059.2025-0008Keywords:
acetyl tetrapeptide-3, cosmetic peptides, solid phase peptide synthesis, anti-hair lossAbstract
Acetyl tetrapeptide-3, a raw material for cosmetic production, was successfully synthesized on the laboratory scale with a high level of purity using the solid-phase peptide synthesis technique. Analysis by high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) confirmed that the yield of acetyl tetrapeptide-3 was over 56% with a purity of 100%. This study supports the development of hair loss and scalp care products incorporating acetyl tetrapeptide-3 as a key active agent.
References
[1] Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, Sansone A & Lombardo F, (2017). Androgenetic alopecia: a review. Endocrine, 57(1), 9-17. https://doi.org/10.1007/s12020-017-1280-y.
[2] Devjani S, Ezemma O, Kelley KJ, Stratton E & Senna M, (2023). Androgenetic alopecia: Therapy Update. Drugs, 83, 701-715. https://doi.org/10.1007/s40265-023-01880-x.
[3] Gupta AK, Talukder M, & Williams G, (2022). Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. Journal of Dermatological Treatment, 33(7), 2946-2962. https://doi.org/10.1080/09546634.2022.2109567
[4] Tian LW, Luo D, Chen D, Zhou H, Zhang XC, Yang XL, Wang YL & Liu W, (2022). Co-delivery of bioactive peptides by nanoliposomes for promotion of hair growth. Journal of Drug Delivery Science and Technology, 72, 103381. https://doi.org/10.1016/j.jddst.2022. 103381.
[5] Lueangarun S & Panchaprateep R, (2020). An herbal extract combination (biochanin A, acetyl tetrapeptide-3, and ginseng extracts) versus 3% minoxidil solution for the treatment of androgenetic alopecia: A 24-week, prospective, randomized, triple-blind, controlled trial. The Journal of Clinical and Aesthetic Dermatology, 13(10), 32-37.
[6] Ferrazzano L, Catani M, Cavazzini A, Martelli G, Corbisiero D, Cantelmi P, Fantoni T, Mattellone A, De Luca C & Felletti S, (2022). Greening the synthesis of peptide therapeutics: an industrial perspective. Green Chemistry, 24, 975-1020. DOI: 10.1039/D0RA07204D
[7] Loing E, Lachance R, Ollier V & Hocquaux M, (2013). A new strategy to modulate alopecia using a combination of two specific and unique ingredients. Journal of Cosmetic Science, 64(1), 45-58.
[8] Knauer S, Koch N, Uth C, Meusinger R, Avrutina O & Kolmar H, (2020). Sustainable peptide synthesis enabled by a transient protecting group. Angewandte Chemie International Edition, 59, 12984-12990. https://doi.org/10.1002/anie.202003676.
[9] El-Faham A, Funosas R S, Prohens R, & Albericio F, (2009). COMU: a safer and more effective replacement for benzotriazole-based uronium coupling reagents. Chemistry - A European Journal, 15 (37), 9404-9416. https://doi.org/10.1002/chem.200900615.
[10] Bui TPH, Phung MP, Doan NH & Luong XH, (2024). Total synthesis of acetyl hexapeptide-8 for use in cosmetics. Journal of Science and Technology, Hanoi University of Industry, 60 (8), 159-163. https://doi.org/10.57001/huih5804.2024.280. (In Vietnamese)
[11] Bui TPH, Doan NH, Hoang VH, Truong TT & Luong XH, (2024). Research on the total synthesis of bioactive pentapeptide-3. Journal of Military Pharmaco-medicine, 49(6), 17-27. https://doi.org/10.56535/jmpm.v49i6.488. (In Vietnamese)
[12] Kaiser E, Colescott RL, Bossinger CD & Cook PI, (1970). Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Analytical biochemistry, 34, 595-598. https://doi.org/10.1016/0003-2697(70)90146-6.
